By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Celsion Corporation 

997 Lenox Drive
Suite 100
Lawrenceville  New Jersey  08648  U.S.A.
Phone: 609-896-9100 Fax: 609-896-2200


Medical Device

Company News
Celsion (CLSN) Reports Second Quarter 2017 Financial Results And Provides Business Update 8/15/2017 7:44:20 AM
Celsion (CLSN) To Hold Second Quarter 2017 Financial Results Conference Call On Tuesday, August 15, 2017 8/8/2017 12:34:15 PM
Data Monitoring Committee Completes Mid-Study Review Of Celsion (CLSN)’s Phase III ThermoDox OPTIMA Study In Primary Liver Cancer 8/7/2017 11:28:10 AM
Celsion (CLSN) To Delist From The Tel Aviv Stock Exchange 8/7/2017 11:08:26 AM
Celsion (CLSN) Announces Latest Translational Data From The OVATION Study In Newly Diagnosed Advanced Ovarian Cancer Patients 8/2/2017 10:19:06 AM
Celsion (CLSN) Announces $5 Million Registered Direct Offering 7/6/2017 8:14:34 AM
Celsion (CLSN) Announces Completion Of OVATION Study And Provides Update On Its Immunotherapy Trial In Advanced Stage III And IV Ovarian Cancer 7/5/2017 8:17:47 AM
Celsion (CLSN) Regains Compliance With NASDAQ Listing Requirements 6/14/2017 12:28:13 PM
Celsion (CLSN) Announces Presentation Of OVATION Study Findings At The ASCO 2017 Annual Meeting 6/5/2017 12:30:21 PM
Celsion (CLSN) Announces Stock Consolidation 5/30/2017 10:55:12 AM